Autolus Therapeutics (AUTL) Deferred Taxes (2020 - 2025)

Autolus Therapeutics (AUTL) has 6 years of Deferred Taxes data on file, last reported at $1.2 million in Q4 2025.

• Quarterly Deferred Taxes rose 929.79% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $286000.0 (up 54.59% YoY) and the FY2025 annual result came in at $286000.0, up 54.59% from the prior year.
• Deferred Taxes rose to $1.2 million in Q4 2025, from -$13000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q4 2025 to a low of -$487000.0 in Q1 2025.
• A 5-year average of $89850.0 and a median of $164000.0 in 2022 frame the typical range for Deferred Taxes.
• The widest YoY moves for Deferred Taxes: up 929.79% in 2025, down 418.92% in 2025.
• Tracing AUTL's Deferred Taxes over 5 years: stood at $420000.0 in 2021, then tumbled by 175.95% to -$319000.0 in 2022, then surged by 246.08% to $466000.0 in 2023, then plunged by 130.26% to -$141000.0 in 2024, then soared by 929.79% to $1.2 million in 2025.
• The last three Deferred Taxes figures came in at $1.2 million (Q4 2025), -$13000.0 (Q3 2025), and -$384000.0 (Q2 2025), per Business Quant data.